2016 BioPacific Conference Agenda:
Theme: Shooting for the Stars – Entering the Dawn of Unprecedented Breakthroughs in Life Sciences & Medicine
May 7th, 2016, Saturday, San Francisco Bay Area at San Mateo Marriott, 1770 South Amphlett Blvd. San Mateo, CA 94402, U.S.A.
| 8:00 AM – 8:45 AM | REGISTRATION |
| Morning Session I: Welcome & CABS K. Fong Award Session Chair: Wentao Zhang, Ph.D. |
|
| 8:45 AM – 8:50 AM | Welcome Remarks Cheni Kwok, Ph.D., CLP, President-Elect of CABS & 2016 BioPacific Conference Organizing Committee Chair |
| 8:50 AM – 9:00 AM | State of the Society Jiangwen Majeti, Ph.D., MBA, President of CABS |
| 9:00 AM – 9:10 AM | CABS K. Fong Special Award: Visionary in Life Sciences Presenter: Kenneth Fong, Ph.D., Chairman, Kenson Ventures Awardee: Gerald Chan, Sc.D., Co-Founder, Morningside |
| 9:10 AM – 10:00 AM | Somewhere Between Science and Humanity Gerald Chan, Sc.D., Co-Founder, Morningside |
| 10:00 AM-10:20 AM | BREAK |
| Morning Session II: Successful Business Models & Entrepreneurship Session Chairs: Jessica Difei Sun, M.D. & Gavin Lu, Ph.D. |
|
| 10:20 AM-10:55 AM | M&A: An Insider’s Perspective Hari Kumar, Ph.D., Ex-Chief Executive Officer & Board of Director, Adheron Therapeutics |
| 10:55 AM – 11:30 AM | Vaccines: Lessons from the Oldest Class of Biologics Piers Whitehead, Executive Vice President & Chief Business Officer, PaxVax |
| 11:30 – 12:00 PM | Life Sciences Parks in China: Growth and Trends Robert Lou, Manager Director, Ningbo Kangtaibo Technology Development Co. Ltd & Hui Zhang, Deputy Director, Ningbo Hangzhou Bay New Zone Investments and Partnership Branch |
| 12:00 PM – 1:00 PM | LUNCH BREAK |
| Afternoon Session I: Life Sciences Breakthroughs & Partnerships Section Chairs: Connie Sun, Ph.D.& Charlene Liao Ph.D. |
|
| 1:00 PM-1:30 PM | Chengdu Kanghong Biotech Co and Conbercept Jinqun Yin, MBA, Vice President, Chengdu Kanghong Pharmaceutical Group |
| 1:30 PM-2:05 PM | Immunotherapy: Past, Present and Future Mark Selby, Ph.D., Senior Director, Immuno-oncology, Bristol-Myers Squibb |
| 2:05 PM-2:40 PM | CRISPR/dCas9 Technology for Genome Manipulation and Disease Research Stanley Qi Ph.D., Assistant Professor, Department of Bioengineering and Department of Chemical and Systems Biology, Stanford University |
| 2:40 PM-3:15 PM | The Art of Partnering Darren Ji, M.D., Ph.D., MBA, Vice President and Global Head of Roche Partnering, Asia and Emerging Markets |
| 3:15 PM-3:45 PM | Key Trends and Case Studies: U.S. – China Cross-Border Life Sciences Investment and Strategic Cooperation Charles Comey, J.D., Partner, Morrison & Foerster LLP |
| 3:45 PM-4:05 PM | COFFEE BREAK |
| Afternoon Session II: Trends in BioPharmaceutical Development – China & Global Considerations Session Chairs: Shichang Miao, Ph.D. & Yang Tian, Ph.D. |
|
| 4:05 PM-5:20 PM | Panel Discussion: BioPharmaceutical Development – China & Global Considerations (Moderator: Shawn Qian, Ph.D.) Xian-Ping Lu, Ph.D., Chief Executive Officer & Chief Scientific Officer, Chipscreen Biosciences Shawn Qian, Ph.D., Co-Founder, Chief Executive Officer & President, NeuPharma Xiaodong Yang, M.D., Ph.D., President and CEO, Apexigen Dan Zhang, M.D., Ph.D., Chairman & Chief Executive Officer, Fountain Medicine Development Ltd |
| 5:20 PM-5:50 PM | Claim Construction Before PTAB and the Courts Thomas L. Irving, J.D., Partner & Wen Li, Ph.D., Associate, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP |
| 5:50 PM-5:55 PM | Introduction to Medicilon Cheni Kwok, Ph.D., CLP, Senior Consultant, Medicilon and Managing Partner, Linear Dreams |
| 5:55 PM-6:00 PM | Introduction to Pharmaron Connie Sun, Ph.D., Senior Vice President, Business and Corporate Development, Pharmaron |
| 6:00 PM-6:45 PM | NETWORKING SESSION |
| 6:45 PM-7:30 PM | DINNER |
| Evening Session: US-China Cross-Border Healthcare Investment & Entrepreneurship Session Chair: Yan Wang, Ph.D. |
|
| 7:30 PM-9:00 PM | Panel Discussion: US-China Cross-Border Healthcare Investment & Entrepreneurship (Moderator: Alexis Ji Ph.D., MBA) Min Cui, Ph.D., Founding Partner & Managing Director, Decheng Capital Alexis Ji, Ph.D., MBA, Principal, WuXi Healthcare Ventures Shawn Lee, Ph.D., Vice-Chairman, Xinbang Pharmaceuticals; President & CEO, CPC Scientific Inc. Cheng Liu, Ph.D., Founder & Chief Executive Officer, Eureka Therapeutics Vincent Liu, Ph.D., Senior Consultant, WanbangBioPharmaceutical, Shanghai Fosun Pharmaceutical (Group) Co. Ltd. Yuwen Liu, Founding Partner, Bohe Angel Fund James Zhao, M.D., Founding Partner, LYFE Capital Darren Ji, M.D., Ph.D., MBA, Vice President and Global Head of Roche Partnering, Asia and Emerging Markets Jennifer Hu, Ph.D., Venture Partner, Qiming Venture Partners |
| 9:00pm | CONFERENCE ADJOURNED |